MRKR
MARKER THRPTCS (MRKR)
NASDAQ
$1.44-$0.01 (-0.97%)
Price as of Jun 03, 2026 7:46 PM EDT
  • $26.2M
    Market Cap
  • -3.97%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
12/31/2022
Income Statement
Total Operating Revenue
3.5M
-46.19%
6.6M
+99.06%
3.3M
-63.26%
9.0M
+625.90%
Cost of Revenue
3.2M
-44.83%
5.8M
+258.02%
1.6M
N/A
N/A
N/A
Gross Profit
346,669
-56.18%
791,080
-53.22%
1.7M
-81.24%
9.0M
+625.90%
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-11.8M
-12.39%
-13.5M
+29.29%
-10.4M
-60.15%
-26.1M
-5.96%
Depreciation and Amortization Expense
N/A
N/A
N/A
N/A
N/A
N/A
2.8M
+29.79%
Total Operating Expenses
16.4M
-7.18%
17.7M
-1.02%
17.9M
-54.07%
39.0M
-4.32%
Operating Profit
-12.9M
+15.94%
-11.1M
-23.75%
-14.6M
-51.31%
-29.9M
-24.15%
Interest Income
594,206
+35.97%
437,010
-18.95%
539,158
+117.35%
248,063
+4,251.98%
Interest Expense
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Interest Income and Expense and Net
594,206
+35.97%
437,010
-18.95%
539,158
+117.35%
248,063
+4,251.98%
Total Nonoperating Income and Expense
117,444
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Income before Taxes
-12.2M
+14.02%
-10.7M
-23.93%
-14.0M
-53.11%
-29.9M
-24.15%
Income Taxes
-15,156
-130.34%
49,953
+1,259.27%
3,675
N/A
N/A
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-12.2M
+13.35%
-10.7M
+30.28%
-8.2M
-72.48%
-29.9M
-28.53%
Net Income from Continuing Operations Applicable to Common
-12.2M
+13.49%
-10.7M
-23.60%
-14.0M
-53.07%
-29.9M
-28.53%
Basic EPS and Net Income
-0.79
-33.61%
-1.19
+26.60%
-0.94
-73.74%
-3.58
+550.91%
Diluted EPS and Net Income
-0.79
-33.61%
-1.19
+26.60%
-0.94
-73.74%
-3.58
+550.91%
Basic Weighted Average Shares
15.3M
+70.49%
9.0M
+1.94%
8.8M
+5.49%
8.4M
-89.08%
Diluted Weighted Average Shares
15.3M
+70.49%
9.0M
+1.94%
8.8M
+5.49%
8.4M
-89.08%
Balance Sheet
Cash and Cash Equivalents
16.1M
-16.28%
19.2M
+27.01%
15.1M
+28.26%
11.8M
-72.18%
Short-Term Investments
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
16.1M
-16.28%
19.2M
+27.01%
15.1M
+28.26%
11.8M
-72.18%
Total Current Assets
19.1M
-13.40%
22.0M
+28.58%
17.1M
+3.06%
16.6M
-63.86%
Accumulated Depreciation
N/A
N/A
N/A
N/A
N/A
N/A
5.3M
+92.48%
Property and Plant and Equipment and Net
N/A
N/A
N/A
N/A
N/A
N/A
12.3M
0.00%
Total Long-Term Assets
N/A
N/A
N/A
N/A
N/A
N/A
17.8M
-19.64%
Total Assets
19.1M
-13.40%
22.0M
+28.58%
17.1M
-50.24%
34.4M
-49.48%
Income Taxes Payable
N/A
N/A
N/A
N/A
N/A
N/A
2.4M
0.00%
Total Short-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
2.5M
N/A
Total Current Liabilities
2.3M
-34.36%
3.5M
+12.67%
3.1M
-60.49%
7.8M
-39.68%
Total Long-Term Debt
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Total Long-Term Liabilities
N/A
N/A
N/A
N/A
N/A
N/A
7.0M
-37.42%
Total Liabilities
2.3M
-34.36%
3.5M
+12.67%
3.1M
-79.25%
14.8M
-38.63%
Retained Earnings
-459.2M
+2.72%
-447.0M
+2.46%
-436.3M
+1.92%
-428.0M
+7.52%
Total Stockholders Equity
16.8M
-9.49%
18.6M
+32.06%
14.1M
-28.31%
19.6M
-55.44%
Total Shares Outstanding
16.7M
+56.07%
10.7M
+20.22%
8.9M
+5.95%
8.4M
-89.89%
Cash Flow
Cash from Operating Activities
-12.0M
+10.12%
-10.9M
-33.64%
-16.4M
-39.05%
-27.0M
-1.13%
Capital Expenditures
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Investing Activities
N/A
N/A
18.7M
0.00%
18.7M
+477.42%
-4.9M
+57.93%
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
9.9M
-34.20%
15.0M
+1,256.54%
1.1M
+446.74%
202,130
-99.62%
Financials Ratio
Gross Margin
9.77%
-18.56%
12.00%
-76.50%
51.07%
N/A
N/A
N/A
Operating Margin
-363.45%
+115.46%
-168.69%
-61.69%
-440.37%
+32.55%
-332.23%
-89.55%
Return on Assets
-59.20%
+7.99%
-54.82%
+71.55%
-31.96%
-45.25%
-58.37%
-20.73%
Return on Equity
-68.81%
+4.55%
-65.81%
+34.45%
-48.95%
-48.00%
-94.14%
-19.83%
Revenue Growth
-46.19%
-146.63%
99.06%
+256.58%
-63.26%
-110.11%
625.90%
+277.02%
Current Ratio
8.39
+31.92%
6.36
+14.12%
5.57
+160.81%
2.14
-40.08%
Cash Ratio
7.07
+27.54%
5.54
+12.72%
4.91
+224.58%
1.51
-53.87%
Debt-to-Equity Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Debt-to-Assets Ratio
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow